Centre Hospitalier Pays de Morlaix
- Address
- lock Available on a paid plan
Oncology and Lung Cancer Research
At Centre Hospitalier Pays de Morlaix, the oncology program includes studies focused on neoplasms, especially small cell lung cancer and non-small cell lung cancer. These trials are designed to test new treatment combinations and improve outcomes for patients with advanced or metastatic disease.
- Testing new therapy strategies for extensive-stage small cell lung cancer
- Evaluating maintenance treatment approaches in metastatic non-squamous lung cancer
- Assessing immunotherapy-based options for older adults with advanced non-small cell lung cancer
This research reflects a strong interest in improving the effectiveness of cancer care while tailoring treatment to different patient groups.
Colorectal and Digestive System Cancer Studies
The site is active in digestive system diseases and neoplasms, with a major focus on colon carcinoma, colon cancer, and ampullary adenocarcinoma. These trials aim to refine treatment after surgery, explore targeted therapy, and support better disease control in colorectal cancers.
- Studying treatment effectiveness in colon cancer guided by circulating tumor DNA findings
- Evaluating targeted therapy for BRAF V600E-mutated localized colon or upper rectum cancer
- Comparing adjuvant treatment strategies after resection of ampullary adenocarcinoma
- Assessing relapse prevention in older patients after stage III colon or upper rectal cancer surgery
These studies support more precise and effective approaches to gastrointestinal cancer care.
Thrombosis and Cardiovascular Research
Clinical trials in cardiovascular diseases and immune system diseases at this site include work on venous thromboembolism, deep vein thrombosis, and pulmonary embolism. The research is aimed at better prevention, improved screening, and reducing recurrence of clot-related events.
- Testing methods to detect hidden cancer in patients with unprovoked venous thromboembolism
- Evaluating medicines for preventing recurrent VTE and related clotting complications
- Studying prevention strategies in patients with cancer and recent thromboembolic events
This work combines cancer and clotting research to improve safety and long-term outcomes for higher-risk patients.
Respiratory Infection and Pulmonary Disease Research
The site also contributes to studies in respiratory tract diseases and bacterial infections and mycoses, including respiratory tract infection and Mycobacterium avium complex lung disease. The purpose of these trials is to compare treatment options and improve recovery in patients with lung and infection-related conditions.
- Comparing treatment options for Mycobacterium avium complex pulmonary infection
- Evaluating interventions for hospitalized patients with acute respiratory tract infection
- Exploring better ways to support recovery in serious lung infections
These studies aim to improve infection management and help clinicians choose effective therapies for respiratory illness.
Blood Disorders and Inflammatory Disease Studies
Research at Centre Hospitalier Pays de Morlaix includes immune system diseases and neoplasms, with attention to Philadelphia-negative myeloproliferative neoplasms and polymyalgia rheumatica. The trials are designed to test better ways to prevent complications and reduce disease activity.
- Studying prevention of clotting events in myeloproliferative neoplasms
- Evaluating treatment approaches for polymyalgia rheumatica
- Assessing therapies that may lower inflammation and improve symptom control
This area of research focuses on safer prevention strategies and more effective control of chronic inflammatory and blood-related disorders.
Diagnostic and Supportive Care Research
The site’s portfolio also includes analytical, diagnostic and therapeutic techniques and equipment, with studies looking at better screening, monitoring, and supportive care in complex illness. These projects often support earlier detection and improved management across cancer, clotting, and infection-related conditions.
- Improving diagnostic strategies for patients at risk of hidden disease
- Assessing supportive approaches that may improve patient recovery and safety
- Using clinical research to refine everyday decision-making in oncology and other specialties
By combining diagnosis and treatment-focused research, the site contributes to more practical and patient-centered care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 15 of 60 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 47 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Pays de Morlaix
lock Showing 1 of 18 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial Comparing Azithromycin and Clarithromycin in Mycobacterium Avium Complex Pulmonary Disease Treatment | Centre Hospitalier Universitaire Amiens Picardie | Phase III | Recruiting | Feb 2018 | — |
IMP list
lock Showing 1 of 60 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 3 | Unknown | 2014-12-23 | 2026-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.